Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
…, AB Carvidi, EG Demissie, AA El-Qunni… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2
…, W Kim, MA Paley, M Yang, AB Carvidi, AA El-Qunni… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
Reactogenicity of the Messenger RNA SARS–CoV‐2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease
…, E Demissie, N Pawar, AA El‐Qunni… - Arthritis care & …, 2022 - Wiley Online Library
Objective Little is known regarding the reactogenicity and related SARS–CoV‐2 vaccine
response in patients with chronic inflammatory disease (CID). Our objective was to characterize …
response in patients with chronic inflammatory disease (CID). Our objective was to characterize …
Sleep Disturbance and SARS–CoV‐2 Vaccinations in Patients With Chronic Inflammatory Disease
…, MA Ciorba, E Demissie, A El‐Qunni… - Arthritis Care & …, 2023 - Wiley Online Library
Objective Immunocompromised patients with chronic inflammatory disease (CID) may have
experienced additional psychosocial burden during the COVID‐19 pandemic due to their …
experienced additional psychosocial burden during the COVID‐19 pandemic due to their …
Sleep disturbance improves with SARS‐COV2 vaccinations in patients with Chronic Inflammatory Disease
…, MA Ciorba, E Demissie, A El‐Qunni… - Arthritis Care & …, 2022 - ncbi.nlm.nih.gov
Objective Immunocompromised patients with chronic inflammatory diseases (CID) may have
experienced additional psychosocial burden during the COVID‐19 pandemic due to an …
experienced additional psychosocial burden during the COVID‐19 pandemic due to an …
[HTML][HTML] IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE …
…, AB Carvidi, E Demissie, AA El-Qunni… - …, 2022 - pesquisa.bvsalud.org
Background: Waning levels of anti-SARS-CoV-2 Spike (S) antibodies, particularly neutralizing,
are associated with the risk of breakthrough infections. The impact of immunosuppression …
are associated with the risk of breakthrough infections. The impact of immunosuppression …
LSO-049 Greater social vulnerability associated with greater glucocorticoid use in patients with SLE
A Som, L Mcmorrow, L Chen, D Sen, A El-qunni… - 2023 - lupus.bmj.com
Background Patients with SLE experience substantial health disparities. Studying the effect
of spatial context on health outcomes has become a focus in health disparities research. The …
of spatial context on health outcomes has become a focus in health disparities research. The …
[CITATION][C] Sleep disturbance improves with SARS-COV2 vaccinations in patients with rheumatologic and chronic inflammatory diseases
…, M Ciorba, E Demissie, AA El-Qunni… - Arthritis & …, 2021 - pesquisa.bvsalud.org
Sleep Disturbance Improves with SARS-COV2 Vaccinations in Patients with Rheumatologic and
Chronic Inflammatory Diseases | Arthritis & Rheumatology; 73:3316-3318, 2021. | Web of …
Chronic Inflammatory Diseases | Arthritis & Rheumatology; 73:3316-3318, 2021. | Web of …
AB0616 GREATER SOCIAL VULNERABILITY ASSOCIATED WITH GREATER GLUCOCORTICOID USE IN PATIENTS WITH SLE
A Som, L Mcmorrow, L Chen, D Sen, A El-Qunni… - 2023 - ard.bmj.com
Background Patients with SLE experience substantial health disparities. Studying the effect
of spatial context on health outcomes has become a focus in health disparities research. The …
of spatial context on health outcomes has become a focus in health disparities research. The …
[CITATION][C] Reactogenicity of the SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with Autoimmune and Inflammatory Disease
…, E Demissie, N Pawar, AA El-Qunni… - Arthritis & …, 2021 - pesquisa.bvsalud.org
Reactogenicity of the SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with
Autoimmune and Inflammatory Disease | Arthritis & Rheumatology; 73:220-223, 2021. | Web of …
Autoimmune and Inflammatory Disease | Arthritis & Rheumatology; 73:220-223, 2021. | Web of …